Meridian Wealth Management, LLC Lantern Pharma Inc. Transaction History

Meridian Wealth Management, LLC

  • $2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$3.91 - $9.51 $58,434 - $142,126
14,945 New
14,945 $69,000
Q4 2023

Feb 08, 2024
BUY
$2.48 - $4.39 $7,440 - $13,169
3,000 Added 18.01%
19,660 $84,000
Q3 2023

Oct 17, 2023
BUY
$3.41 - $5.51 $56,810 - $91,796
16,660 New
16,660 $56,000

Others Institutions Holding LTRN

# of Institutions
34
Shares Held
1.31M
Call Options Held
39.8K
Put Options Held
6.1K
View Full List

About Lantern Pharma Inc.

LTRN Quotes by TradingView
  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $37M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track Meridian Wealth Management, LLC Portfolio

Follow Meridian Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email